DIM shows promise in predicting Alzheimer's progression.
problem Predicting Alzheimer's disease progression from brain imaging.
method Used variants of Deep InfoMax (DIM) for brain imaging analysis.
result DIM outperforms supervised AlexNet and ResNet in Alzheimer's progression prediction.
Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical benefits and may provide insight for combating the disease. Machine learning, and more specifically deep neural networks, have been shown to have great efficacy in this domain. These algorithms often use neurological ima…
For precision medicine and personalized treatment, we need to identify predictive markers of disease. We focus on Alzheimer's disease (AD), where magnetic resonance imaging scans provide information about the disease status. By combining imaging with genome sequencing, we aim at identifying rare genetic markers associa…
New method uses DNN for genetic variant identification, controlling randomness and improving interpretability.
problem Challenges in interpreting deep neural networks for genetic variant identification.
method Interpretable neural network model with controlled variable selection using ensembling, knockoffs, and de-randomization.
result The proposed method leads to more discoveries compared to conventional methods.
A novel method predicts shape development using Riemannian shape spaces.
problem Predicting future shape development from a single observation.
method Proposes a novel prediction method that encodes shapes in a Riemannian shape space and learns hierarchical statistical models.
result Outperforms deep learning-supported variants and state-of-the-art methods in predicting shape development.
Novel method identifies proteomic risk markers for Alzheimer disease.
problem Lack of comprehensive proteomic risk markers for Alzheimer disease diagnosis.
method Deep belief network-based feature selection method using proteomic and clinical data.
result Identified an optimal subset of proteins achieving 90% accuracy in Alzheimer disease diagnosis.
ADReSS Challenge at INTERSPEECH 2020 benchmarks speech recognition for Alzheimer's dementia.
problem Automated recognition of Alzheimer's dementia from spontaneous speech.
method Provides a benchmark speech dataset, defines two tasks (classification and regression), and presents baseline models.
result Demonstrates the feasibility of automated speech recognition for Alzheimer's dementia.
DKT transfers biomarker information between neurodegenerative diseases.
problem Estimating biomarker trajectories in rare neurodegenerative diseases with limited data.
method DKT is a joint-disease generative model that transfers biomarker progressions from common neurodegenerative diseases to rare ones.
result DKT estimates plausible multimodal biomarker trajectories in rare diseases like PCA using only unimodal data.
Deep learning ensemble improves Alzheimer vs. Mild Cognitive Impairment diagnosis.
problem Differentiating Alzheimer Disease from Mild Cognitive Impairment.
method Hybrid deep learning ensemble framework using MRI slices, pretrained models, and stacked ensemble learning.
result State-of-the-art accuracy (99.21%) for Alzheimer vs. Mild Cognitive Impairment classification.
Proposes a new Alzheimer's disease simulator for causal effect estimation.
problem Lack of suitable benchmarks for evaluating causal effect estimators in real-world healthcare data.
method Developed a simulator of Alzheimer's disease using ADNI dataset, incorporating various parameters to model complexities.
result Compared estimators of average and conditional treatment effects using the new simulator.
We develop three efficient approaches for generating visual explanations from 3D convolutional neural networks (3D-CNNs) for Alzheimer's disease classification. One approach conducts sensitivity analysis on hierarchical 3D image segmentation, and the other two visualize network activations on a spatial map. Visual chec…
Paper proposes machine learning model for early Alzheimer's diagnosis.
problem Early and accurate diagnosis of Alzheimer's Disease.
method Machine learning models, demographic, biomarker, and cognitive test data.
result 90% accuracy and 87% accuracy in predicting Alzheimer's development.
A new Mapper algorithm optimizes data visualization through automatic parameter tuning.
problem Manual parameter tuning and fixed intervals limit the performance of the standard Mapper algorithm.
method Introduces a soft Mapper framework based on Gaussian mixture models for automatic interval construction and optimization via stochastic gradient descent.
result Demonstrates effectiveness in capturing underlying topological structures and identifying distinct subgroups.
Alzheimer's disease (AD) is a degenerative brain disease impairing a person's ability to perform day to day activities. The clinical manifestations of Alzheimer's disease are characterized by heterogeneity in age, disease span, progression rate, impairment of memory and cognitive abilities. Due to these variabilities, …
System diagnoses Alzheimer's disease from spoken language using multi-modal features.
problem Early diagnosis of Alzheimer's disease from spoken language.
method Classification system based on spoken language using three approaches (N-gram, i-vector, x-vector).
result Accuracy of 83.6% on the cookie picture description task from Pitt Corpus dementia bank.
Wide and deep neural network predicts Alzheimer's progression from shape and clinical data.
problem Predicting Alzheimer's disease progression from shape and clinical data.
method Fused anatomical shape and tabular clinical data in a neural network, employing survival analysis loss.
result The model outperforms shape and clinical models individually.
Improved CNNs detect Alzheimer's with 14% accuracy boost.
problem Early detection of Alzheimer's Disease using MRI scans.
method Optimized 3D CNNs with instance normalization, spatial downsampling, model widening, and age information.
result 14% increase in test accuracy distinguishing AD, MCI, and controls.
New model detects Alzheimer's and severity from speech, cognitive, and language data.
problem Detecting Alzheimer's disease and its severity from multimodal data.
method Multimodal ensemble system using acoustic, cognitive, and linguistic features.
result State-of-the-art accuracy and robustness in AD detection and MMSE score regression.
Early prognosis of Alzheimer's dementia is hard. Mild cognitive impairment (MCI) typically precedes Alzheimer's dementia, yet only a fraction of MCI individuals will progress to dementia, even when screened using biomarkers. We propose here to identify a subset of individuals who share a common brain signature highly p…
Genome-wide association studies (GWA studies or GWAS) investigate the relationships between genetic variants such as single-nucleotide polymorphisms (SNPs) and individual traits. Recently, incorporating biological priors together with machine learning methods in GWA studies has attracted increasing attention. However, …
Deep learning ensemble improves Alzheimer's disease classification accuracy.
problem Improving diagnostic accuracy for Alzheimer's disease.
method Proposes a deep ensemble learning framework integrating multisource data and expert wisdom.
result 4% improvement in classification accuracy compared to existing methods.
Bayesian meta-learning predicts Alzheimer's disease progression.
problem Predicting individual Alzheimer's disease progression from limited data.
method Bayesian meta-learning approach that dynamically predicts disease score distributions.
result Bayesian meta-learner outperforms single-task models and deterministic meta-learners, especially for long-term predictions.
Models predict Alzheimer's Dementia from spontaneous speech with high accuracy.
problem Early diagnosis of Alzheimer's Dementia (AD) through spontaneous speech analysis.
method Compared natural language processing techniques including SVM, GBDT, CRFs, and Transformer-based models.
result Top models achieve 0.81-0.82 test set scores for AD vs controls and 4.58 RMSE for Mental Mini State Exam scores.
Alzheimer's disease is the most common dementia leading to an irreversible neurodegenerative process. To date, subject revealed advanced brain structural alterations when the diagnosis is established. Therefore, an earlier diagnosis of this dementia is crucial although it is a challenging task. Recently, many studies h…
SVEHNN explains DNN diagnoses of Alzheimer's disease from neuroanatomy and biomarkers.
problem Interpreting deep neural networks for medical diagnosis, especially in the clinic.
method Shapley Value Explanation of Heterogeneous Neural Networks (SVEHNN) for local explanations.
result SVEHNN provides interpretable explanations for DNN diagnoses with reduced runtime.
Project predicts Alzheimer's progression using neural networks and novel data processing.
problem Difficulty in early identification of Alzheimer's patients.
method Used machine learning, specifically neural networks, and a novel pre-processing technique.
result Neural network model accurately predicts AD progression with high accuracy.
StaPLR improves Alzheimer's disease classification by identifying important MRI scan types and measures.
problem Classifying Alzheimer's disease using multi-source MRI data.
method Stacked penalized logistic regression (StaPLR) with hierarchical multi-view structure and new view importance measure.
result StaPLR identifies the most important MRI scan types and measures for Alzheimer's disease classification.
HMRNN combines HMMs and neural networks for Alzheimer's disease forecasting.
problem Improving disease progression modeling with hidden states not fully known.
method Developed HMRNN combining HMMs and recurrent neural networks.
result HMRNN improves disease forecasting and offers novel clinical interpretation.
We propose a non-parametric regression methodology, Random Forests on Distance Matrices (RFDM), for detecting genetic variants associated to quantitative phenotypes representing the human brain's structure or function, and obtained using neuroimaging techniques. RFDM, which is an extension of decision forests, requires…
Paper introduces a framework for diagnosing Alzheimer's disease using higher-order topological features from fMRI.
problem Diagnosing Alzheimer's disease using brain network topology.
method Persistent homology to extract higher-order features (cycles, cavities) from fMRI data.
result Framework significantly outperforms existing methods in AD classification.
Transformers improve Alzheimer's disease progression prediction by accounting for irregular biomarker histories.
problem Difficult prediction of medium-horizon Alzheimer's disease progression due to tied clinical scores and irregular biomarker observations.
method Developed a residual gap-aware transformer that combines statistical reference with transformer-based residual learning.
result The proposed model reduces mean error and improves prediction-observation correlation compared to baseline models.
The paper generates future brain imaging sequences for Alzheimer's disease detection.
problem Understanding brain aging and neurodegenerative diseases through sequential image data.
method Formulated a min-max problem based on f-divergence to learn a time series generator using a deep neural network. result Generated image sequences converge to the latent truth under specific conditions, enhancing downstream tasks like Alzheimer's disease detection.
PETNet improves AD diagnosis using graph-based CNN on PET images.
problem Early diagnosis of Alzheimer's Disease using PET imaging.
method PETNet, a graph-based CNN architecture for 3D PET image analysis.
result PETNet shows improved performance over deep learning and other methods on ADNI dataset.
NEURO-DRAM improves neuroimaging classification accuracy.
problem Improper use of traditional computer vision models in neuroimaging.
method 3D recurrent visual attention model trained with reinforcement learning.
result NEURO-DRAM achieves state-of-the-art accuracy in Alzheimer's disease prediction.
THS-GAN uses tensorizing and high-order pooling for AD diagnosis.
problem Early diagnosis of Alzheimer's Disease (AD) using MRI images.
method Tensorizing a three-player cooperative game framework with high-order pooling for MRI images.
result THS-GAN achieves superior performance in AD diagnosis compared to existing methods.
Most approaches to machine learning from electronic health data can only predict a single endpoint. Here, we present an alternative that uses unsupervised deep learning to simulate detailed patient trajectories. We use data comprising 18-month trajectories of 44 clinical variables from 1908 patients with Mild Cognitive…
Novel approach combines local and global brain changes for AD prediction.
problem Detecting Alzheimer's disease through local and global brain changes.
method Patch-based 3D-CNNs combined with global topological features for multi-scale brain tissue connectivity.
result Average precision score of 0.95 for classifying cognitively normal subjects and AD patients (prevalence ~55%).
Ensemble model predicts AD progression from CN status with high accuracy.
problem Early prediction of clinical progression from cognitively normal to mild cognitive impairment or Alzheimer's disease.
method Ensemble survival analysis combining penalized Cox regression, advanced survival models, and aggregation techniques.
result Ensemble model achieved peak C-index of 0.907 and integrated time-dependent AUC of 0.904, outperforming baseline models.
Accurate diagnosis of Alzheimer's Disease (AD) entails clinical evaluation of multiple cognition metrics and biomarkers. Metrics such as the Alzheimer's Disease Assessment Scale - Cognitive test (ADAS-cog) comprise multiple subscores that quantify different aspects of a patient's cognitive state such as learning, memor…
A CNN on semi-regular meshes classifies brain diseases from MRI scans.
problem Classifying brain diseases from MRI scans.
method Developed a vertex-based graph CNN for semi-regular triangulated meshes.
result Vertex-based graph CNN outperformed spectral graph CNN in classifying MCI and AD.
FLARe model forecasts Alzheimer's progression using learned latent representations.
problem Forecasting Alzheimer's disease progression at the patient level.
method Generates a sequence of latent representations from longitudinal data across multiple modalities, incorporating time horizon.
result Outperforms baseline in forecasting accuracy and F1 score, robustly handling missing visits.
New method predicts AD progression using MEG brain networks.
problem Early diagnosis and prediction of Alzheimer's disease progression.
method MG2G, a deep learning method that maps brain networks into a latent space.
result MG2G detects subtle brain connectivity patterns and predicts AD progression.
Wavelets model complex interactions in spatial transcriptomics.
problem Capturing higher-order relationships in spatial transcriptomics data.
method Hypergraph diffusion wavelets for representing hyperedges.
result Wavelets effectively represent disease-relevant cellular niches in Alzheimer's disease.
Joint models for longitudinal and time-to-event data are commonly used in longitudinal studies to forecast disease trajectories over time. Despite the many advantages of joint modeling, the standard forms suffer from limitations that arise from a fixed model specification and computational difficulties when applied to …
Pattern recognition methods using neuroimaging data for the diagnosis of Alzheimer's disease have been the subject of extensive research in recent years. In this paper, we use deep learning methods, and in particular sparse autoencoders and 3D convolutional neural networks, to build an algorithm that can predict the di…
Method predicts biomarker trajectories with uncertainty bands for Alzheimer's disease.
problem Uncertainty in biomarker predictions poses risks in clinical deployment.
method Conformal prediction for randomly-timed biomarker trajectories.
result Conformal bands achieve desired coverage and are tighter than baseline.
Study examines APOE's impact on AD progression using a novel DEBM approach.
problem Understanding APOE's role in AD progression and developing targeted clinical trials.
method Developed a discriminative event-based model (DEBM) and proposed a stratified approach to improve model accuracy.
result Identified APOE carriers' impact on AD progression timeline, aiding clinical trial selection.
Most machine learning classifiers give predictions for new examples accurately, yet without indicating how trustworthy predictions are. In the medical domain, this hampers their integration in decision support systems, which could be useful in the clinical practice. We use a supervised learning approach that combines E…